细胞内膜网膜压力-MMRN1正面反有助于小细胞肺癌中对西斯普拉丁的耐药性
Mingxin Liu1,2, Peihong Hu1,2, Bo Tang2,3
1Department of Thoracic Surgery, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, University of Electronic Science and Technology of China, Chengdu, China.
Journal of thoracic disease
|January 20, 2025
概括
小细胞肺癌 (SCLC) 对西斯普拉丁化疗的耐药性可以通过向多重素-1 (MMRN1) 来克服. 外体MMRN1通过维持内质网膜应激来促进西斯普拉丁耐药性,为SCLC患者提供潜在的治疗策略.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 生物化学 生物化学
背景情况:
- 小细胞肺癌 (SCLC) 是一种具有不良预后的侵袭性恶性瘤,通常用西斯普拉丁化疗 (CDDP) 治疗.
- 获得对CDDP的耐药性是一个主要的挑战,导致SCLC患者的疾病进展和复发.
- 了解CDDP耐药机制对于识别生物标志物和开发有效的治疗策略至关重要.
研究的目的:
- 调查多美林-1 (MMRN1) 在SCLC中获得的西斯普拉丁耐药性中的作用.
- 为了确定SCLC中CDDP耐药性的潜在生物标志物.
- 探索MMRN1作为克服CDDP耐药性的治疗点.
主要方法:
- 在具有或没有CDDP耐药性的SCLC患者中,使用液态染色体-并联质谱法 (LC-MS/MS) 分析了差异性外体蛋白质.
- 来自SCLC患者的RNA测序数据和临床信息被分析为预后价值.
- 建立了一个CDDP耐性SCLC细胞系模型来研究MMRN1的功能.
主要成果:
- 在CDDP耐性SCLC患者和细胞系中,MMRN1水平升高.
- 减少MMRN1恢复了CDDP敏感性,而其过度表达则赋予了耐药性.
- 外体MMRN1从耐药转移到敏感的SCLC细胞,调解耐药性.
- 治疗CDDP诱导了内等质网膜 (ER) 压力和上调的MMRN1,该MMRN1与BiP相互作用,以维持ER压力.
结论:
- 外体MMRN1是SCLC中CDDP耐药性的潜在生物标志物.
- 通过与BiP的相互作用,MMRN1通过维持ER压力来促进CDDP抵抗.
- 向MMRN1代表了一种有希望的治疗策略,以克服SCLC中CDDP耐药性.
相关概念视频
02:56Treatment Resistant Cancers
3.2K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.2K
01:31Regulation of the Unfolded Protein Response
2.4K
Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
2.4K
03:03mTOR Signaling and Cancer Progression
3.7K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.7K
02:23Abnormal Proliferation
4.4K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.4K
02:37DNA Damage can Stall the Cell Cycle
9.0K
In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
9.0K
01:37The Unfolded Protein Response
4.4K
The ER is the hub of protein synthesis in a cell. It has robust systems to quality control protein folding and also for degradation of terminally misfolded proteins. Under normal conditions, a small proportion of misfolded proteins that cannot be salvaged need to be transported to the cytoplasm by the ER-associated degradation or ERAD pathways. However, if the ERAD cannot handle the misfolded proteins, the cell activates the unfolded protein response or UPR to adjust the protein folding...
4.4K